Nucoxia Relax Tablet
By Nucoxia MR
Rx
10 Tablet in a Strip

Composition
Etoricoxib(90mg) + Thiocolchicoside(8mg)

Manufacturer - Zydus Cadila
Zydus Tower, Satellite Cross Roads,Ahmedabad – 380015 Gujarat, India.

Expires on or after
April, 2026

liver
When using Nucoxia Relax Tablet, it is important to be cautious if you have liver disease. Patients with liver disease may require a dose adjustment while taking Nucoxia Relax Tablet, so it is essential to consult your doctor before starting the medication. It is advised not to use Nucoxia Relax Tablet in patients with severe liver disease. If you have liver impairment or any concerns about your liver health, please consult your doctor as dose adjustment may be necessary.

kidney
Nucoxia Relax Tablet is likely safe for patients with kidney disease. It may not require dose adjustment in these patients, but not recommended for severe kidney disease. Consult your doctor for any concerns or kidney impairment.

alcohol
When taking Nucoxia Relax Tablet, avoid alcohol as it can lead to increased drowsiness and higher risk of stomach bleeding.

driving
To ensure safety, refrain from driving if you feel dizzy, sleepy, or experience vertigo while taking Nucoxia Relax Tablet. It may affect your ability to drive safely, so avoid driving if you have these symptoms.

pregnancy
Nucoxia Relax Tablet may not be safe to use during pregnancy, as it can have harmful effects on the baby based on animal studies. Your doctor will assess the risks and benefits before prescribing it. Kindly consult your doctor for advice.

breastfeeding
It is better to consult your doctor before using Nucoxia Relax Tablet during breastfeeding as there is no specific safety advice available. Your doctor will determine if it is safe for breastfeeding mothers to take Nucoxia Relax Tablet 10's.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹513
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024